Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $702.12 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $235.33 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $156.95 | 5 | $0 (2024) |
| ABBVIE INC. | $139.49 | 4 | $0 (2024) |
| Genentech USA, Inc. | $86.67 | 1 | $0 (2024) |
| ViiV Healthcare Company | $23.92 | 1 | $0 (2024) |
| Dexcom, Inc. | $22.54 | 1 | $0 (2023) |
| Exact Sciences Corporation | $20.58 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $16.64 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $441.46 | 13 | GlaxoSmithKline, LLC. ($156.95) |
| 2023 | $260.66 | 7 | Gilead Sciences, Inc. ($126.76) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.47 | General |
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: VACCINE | ||||||
| 09/17/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $67.14 | General |
| Category: HCV | ||||||
| 09/11/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $23.92 | General |
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $86.67 | General |
| Category: Immunology | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: RESPIRATORY | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: RESPIRATORY | ||||||
| 04/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.96 | General |
| 03/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $85.25 | General |
| Category: VIROLOGY | ||||||
| 08/11/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 06/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $91.72 | General |
| Category: HCV | ||||||
| 05/03/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Endocrinology | ||||||
| 04/06/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.16 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 29 | $841.00 | $266.56 |
| 2022 | 1 | 20 | 30 | $870.00 | $277.67 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 29 | $841.00 | $266.56 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 20 | 30 | $870.00 | $277.67 | 31.9% |
About Danielle Sorano, APRN
Danielle Sorano, APRN is a Gerontology healthcare provider based in Norwich, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2021. The National Provider Identifier (NPI) number assigned to this provider is 1144995424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Danielle Sorano, APRN has received a total of $702.12 in payments from pharmaceutical and medical device companies, with $441.46 received in 2024. These payments were reported across 20 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($702.12).
As a Medicare-enrolled provider, Sorano has provided services to 41 Medicare beneficiaries, totaling 59 services with total Medicare billing of $544.23. Data is available for 2 years (2022–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Gerontology
- Location Norwich, CT
- Active Since 08/10/2021
- Last Updated 08/10/2021
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1144995424
Products in Payments
- Epclusa (Drug) $158.86
- AREXVY (Drug) $136.55
- Xolair (Biological) $86.67
- MAVYRET (Drug) $85.25
- UBRELVY (Drug) $41.29
- Dexcom G6 Transmitter (Medical Supply) $22.54
- Cologuard Collection Kit (Device) $20.58
- TRELEGY ELLIPTA (Drug) $20.40
- GARDASIL (Biological) $16.64
- VRAYLAR (Drug) $12.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.